Geode Capital Management, LLC Rvl Pharmaceuticals PLC Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.02 - $1.61 $2,941 - $4,643	2,884 Added 0.95%	307,266 $344,000
Q3 2022 Nov 14, 2022	BUY	$1.28 - $2.91 $53,254 - $121,070	41,605 Added 15.83%	304,382 $639,000
Q2 2022 Aug 12, 2022	BUY	$1.21 - $1.81 $11,727 - $17,542	9,692 Added 3.83%	262,777 $357,000
Q1 2022 May 13, 2022	BUY	$1.03 - $2.01 $112,705 - $219,940	109,423 Added 76.17%	253,085 $427,000
Q4 2021 Feb 11, 2022	SELL	$0.98 - $3.06 $2,714 - $8,476	-2,770 Reduced 1.89%	143,662 $155,000
Q3 2021 Nov 12, 2021	SELL	$2.79 - $4.19 $25,907 - $38,908	-9,286 Reduced 5.96%	146,432 $431,000
Q2 2021 Aug 13, 2021	SELL	$2.8 - $3.78 $238,036 - $321,349	-85,013 Reduced 35.31%	155,718 $468,000
Q1 2021 May 12, 2021	BUY	$3.26 - $4.84 $47,905 - $71,123	14,695 Added 6.5%	240,731 $784,000
Q4 2020 Feb 12, 2021	BUY	$4.12 - $6.29 $29,256 - $44,665	7,101 Added 3.24%	226,036 $931,000
Q3 2020 Nov 13, 2020	SELL	$4.82 - $8.77 $2,164 - $3,937	-449 Reduced 0.2%	218,935 $1.18 Million
Q2 2020 Aug 13, 2020	BUY	$2.83 - $6.99 $43,582 - $107,646	15,400 Added 7.55%	219,384 $1.48 Million
Q1 2020 May 14, 2020	BUY	$3.18 - $7.0 $210,064 - $462,406	66,058 Added 47.89%	203,984 $648,000
Q4 2019 Feb 13, 2020	BUY	$3.46 - $7.7 $113,280 - $252,098	32,740 Added 31.13%	137,926 $964,000
Q3 2019 Nov 12, 2019	BUY	$2.8 - $3.99 $795 - $1,133	284 Added 0.27%	105,186 $403,000
Q2 2019 Aug 14, 2019	BUY	$2.34 - $4.28 $29,467 - $53,898	12,593 Added 13.64%	104,902 $398,000
Q1 2019 May 14, 2019	BUY	$3.6 - $8.75 $21,574 - $52,438	5,993 Added 6.94%	92,309 $332,000
Q4 2018 Feb 13, 2019	BUY	$6.25 - $9.2 $539,475 - $794,107	86,316 New	86,316 $668,000

Others Institutions Holding RVLP

# of Institutions

Shares Held

92.5K

Call Options Held

Put Options Held

Titleist Asset Management, Ltd. San Antonio, TX

92.5K
Shares

$0
0.02% of portfolio

View Full List

About RVL Pharmaceuticals plc

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

More about RVLP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account